PTC THERAPEUTICS, INC.PTCT
Market cap
$5.9B
P/E ratio
| 2013/12 | 2014/12 | 2015/12 | 2016/12 | 2017/12 | 2018/12 | 2019/12 | 2020/12 | 2021/12 | 2022/12 | 2023/12 | 2024/12 | |
| Depreciation & amortization | - | - | - | - | 18 | 26 | 32 | 43 | 64 | 129 | 237 | 76 |
| Stock-based compensation | 8 | 19 | 34 | 35 | 31 | 33 | 42 | 70 | 104 | 110 | 102 | 75 |
| Cash from operations | -46,922,124 | -57 | -124 | -104 | -10 | -28 | -99 | -194 | -251 | -357 | -158 | -108 |
| Capital expenditures | -845,732 | -5 | -3 | -2 | -3 | -7 | -14 | -18 | -28 | -32 | -28 | -7 |
| Cash from investing | -127,828,463 | -145 | -21 | 104 | 13 | -43 | -387 | -562 | 219 | 290 | -177 | 44 |
| Repayments of term debt | 5 | 0 | - | - | - | - | - | - | - | - | - | - |
| Cash from financing | 187 | 237 | 154 | 1 | 44 | 132 | 613 | 669 | 21 | 168 | 646 | 256 |
| Free cash flow | ||||||||||||
| FCF margin (%) |